Skip to main content
SpringerLink
Log in

Dyskinesia

Research and Treatment

  • Conference proceedings
  • © 1985

Overview

Editors:
  1. Daniel E. Casey

    1. Medical Research, Psychiatry and Neurology Services at the Veterans Administration Medical Center, USA
      Departments of Psychiatry and Neurology at the Oregon Health Sciences University, Portland, USA
      Oregon Regional Primate Research Center, Beaverton, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Thomas N. Chase

    1. Intramural Research Program, National Institute of Neurological and Communicative Disorders and Stroke, Department of Health and Human Services, National Institute of Health, Bethesda, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Anne Vibeke Christensen

    1. H. Lundbeck A/S, Copenhagen-Valby, Denmark

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  4. Jes Gerlach

    1. Department AEH, Sct. Hans Mental Hospital, Roskilde, Denmark

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Psychopharmacology Series (PSYCHOPHARM, volume 2)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (27 papers)

  1. Front Matter

    Pages I-IX
    Download chapter PDF

  2. Preclinical Aspects

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Brain Dopamine Receptors in Schizophrenia and Tardive Dyskinesia

      • P. Seeman
      Pages 2-8

    3. Receptor-Binding Profiles of Neuroleptics

      • J. Hyttel, J.-J. Larsen, A. V. Christensen, J. Arnt
      Pages 9-18

    4. Functional Classification of Different Dopamine Receptors

      • U. Ungerstedt, M. Herrera-Marschitz, L. StÃ¥hle, U. Tossman, T. Zetterström
      Pages 19-30

    5. Pharmacological Properties of Presynaptic Dopamine Receptor Agonists

      • A. Carlsson
      Pages 31-38

    6. Influence of GABA Mimetics and Lithium on Biochemical Manifestations of Striatal Dopamine Target Cell Hypersensitivity

      • B. Scatton, D. Fage, A. Oblin, B. Zivkovic, S. Arbilla, S. Z. Langer et al.
      Pages 39-45

    7. New Aspects on the Role of Dopamine, Acetylcholine, and GABA in the Development of Tardive Dyskinesia

      • J. Scheel-Krüger, J. Arnt
      Pages 46-57

  3. Clinical Aspects

    1. Front Matter

      Pages 63-63
      Download chapter PDF

    2. Is Tardive Dyskinesia a Unique Disorder?

      • C. D. Marsden
      Pages 64-71

    3. Tardive Dyskinesia: Prevalence, Incidence, and Risk Factors

      • J. M. Kane, M. Woerner, J. Lieberman
      Pages 72-78

    4. Involuntary Disorders of Movement in Chronic Schizophrenia — The Role of the Illness and Its Treatment

      • D. G. Cunningham Owens
      Pages 79-87

    5. Tardive Dyskinesia: Reversible and Irreversible

      • D. E. Casey
      Pages 88-97

    6. Pathophysiological Mechanisms Underlying Tardive Dyskinesia

      • J. Gerlach
      Pages 98-103

    7. Chemical and Structural Changes in the Brain in Patients with Movement Disorder

      • A. J. Cross, T. J. Crow, I. N. Ferrier, J. A. Johnson, E. C. Johnstone, F. Owen et al.
      Pages 104-110

    8. Medical Treatment of Dystonia

      • H. Pakkenberg, B. Pedersen
      Pages 111-117

    9. The Effect of Dopamine Antagonists in Spontaneous and Tardive Dyskinesia

      • R. Fog
      Pages 118-121

    10. GABA Dysfunction in the Pathophysiology of Tardive Dyskinesia

      • C. A. Tamminga, G. K. Thaker, T. N. Chase
      Pages 122-127

    11. Clinical Activity of GABA Agonists in Neuroleptic- and L-Dopa-Induced Dyskinesia

      • P. L. Morselli, V. Fournier, L. Bossi, B. Musch
      Pages 128-136
Back to top

Keywords

Editors and Affiliations

  • Medical Research, Psychiatry and Neurology Services at the Veterans Administration Medical Center, USA

    Daniel E. Casey

  • Departments of Psychiatry and Neurology at the Oregon Health Sciences University, Portland, USA

    Daniel E. Casey

  • Oregon Regional Primate Research Center, Beaverton, USA

    Daniel E. Casey

  • Intramural Research Program, National Institute of Neurological and Communicative Disorders and Stroke, Department of Health and Human Services, National Institute of Health, Bethesda, USA

    Thomas N. Chase

  • H. Lundbeck A/S, Copenhagen-Valby, Denmark

    Anne Vibeke Christensen

  • Department AEH, Sct. Hans Mental Hospital, Roskilde, Denmark

    Jes Gerlach

Bibliographic Information

  • Book Title: Dyskinesia

  • Book Subtitle: Research and Treatment

  • Editors: Daniel E. Casey, Thomas N. Chase, Anne Vibeke Christensen, Jes Gerlach

  • Series Title: Psychopharmacology Series

  • DOI: https://doi.org/10.1007/978-3-642-70140-5

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1985

  • Softcover ISBN: 978-3-642-70142-9Published: 23 November 2011

  • eBook ISBN: 978-3-642-70140-5Published: 12 March 2013

  • Series ISSN: 0931-6795

  • Edition Number: 1

  • Number of Pages: X, 230

  • Topics: Pharmacology/Toxicology, Neurology, Internal Medicine, Pathology

Publish with us

Policies and ethics

Back to top

Search

Navigation